Click image to inspect pack details
Orthopaedic Range Marketed by Aerochem Neutron

NUROGENE-NP

Formulation Code AC-457
Commercial Status Active Product Information Available

Product Overview & Formulation Profile

Composition: Methylcobalamin 1500 + Nortriptyline 10 mg + Pregabalin 75mg (tablets). The rationale for the combination is complementary action: Methylcobalamin (active vitamin B12), Nortriptyline (tricyclic agent) and Pregabalin (alpha-2-delta ligand).

Methylcobalamin is the active coenzyme form of vitamin B12, involved in nerve function and haematopoiesis. Nortriptyline is a tricyclic agent that modulates serotonin and noradrenaline reuptake in pain pathways. Pregabalin binds the alpha-2-delta subunit of voltage-gated calcium channels and reduces neuropathic pain signalling.

NUROGENE-NP is a prescription medicine from Aerochem Neutron's orthopaedic range, for use on the prescription of a registered medical practitioner.

Composition & Formulation Details

·       Contains Methylcobalamin 1500 + Nortriptyline 10 mg + Pregabalin 75mg [composition under verification]

·       Methylcobalamin is the active coenzyme form of vitamin B12, involved in nerve function and haematopoiesis

·       Nortriptyline — tricyclic agent that modulates serotonin and noradrenaline reuptake in pain pathways

·       Pregabalin binds the alpha-2-delta subunit of voltage-gated calcium channels and reduces neuropathic pain signalling

·       Presented as tablets

·       Diabetic peripheral neuropathy

·       Post-herpetic neuralgia

·       Other peripheral neuropathic pain

·       Note: indications reflect established uses of the individual molecules; confirm against the CDSCO-approved label for this fixed-dose combination

Safety

·       Contraindicated in patients with known hypersensitivity to any component.

·       Tricyclics carry a warning for suicidality in young people, anticholinergic effects and cardiac conduction effects; avoid after recent myocardial infarction and with MAO inhibitors.

·       May cause dizziness, somnolence and dependence/misuse; caution with CNS depressants and in renal impairment.

·       Pregnancy and lactation: use only if the prescriber judges the benefit to outweigh the risk.

Professional Product Enquiries

Verified product information, formulation specifications, and commercial supply pathways for registered healthcare professionals, institutions, and trade partners.

Product Information

Review verified active composition, strength, dosage form, and packaging details on this page.

View Specifications

Healthcare Professional Enquiry

Request formulation literature, technical specifications, or product communication from our commercial team.

Submit Product Enquiry

Commercial Supply Enquiry

Connect regarding institutional supply requirements, trade distribution, or third-party contract manufacturing.

Commercial Enquiry

Professional Product Information

This product information is intended for registered healthcare professionals, medical practitioners, and authorized distribution partners. Product manufacturing is coordinated through eligible facility partners under applicable licences.

Product Enquiry

Request Formulation Details

Request information about NUROGENE-NP for professional use.

Please enter the numeric sum to verify you are a human visitor.
Approved Resources

Distributor Media

Product Image - NUROGENE-NP
Product Image

NUROGENE-NP — Product Image

Therapeutic Alternatives

Related Formulations

LINKACE Formulation
Orthopaedic Range

LINKACE

View Formulation
DOLOCO AQ Formulation
Orthopaedic Range

DOLOCO AQ

View Formulation
DOLOCO GEL Formulation
Orthopaedic Range

DOLOCO GEL

View Formulation
DOLOCO TAB Formulation
Orthopaedic Range

DOLOCO TAB

View Formulation
Product Information

Need specifications for this formulation?

Request verified product information for professional use, or send a separate business enquiry for manufacturing or partnership discussions.

WhatsApp: +91 9512047000